Christopher Adlbrecht1, Kurt Huber2, Harmony R Reynolds3, Antonio C Carvalho4, Vladimír Džavík5, Philippe Gabriel Steg6, Li Liu7, Paolo Marino8, Camille A Pearte3, James M Rankin9, Harvey D White10, Gervasio A Lamas10, Judith S Hochman11. 1. Department of Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria. 2. 3rd Department of Internal Medicine, Cardiology and Emergency Medicine, Wilhelminen Hospital, Vienna, Austria. 3. Cardiovascular Clinical Research Center, New York University School of Medicine, New York, United States. 4. Hospital Sao Paulo, Moema, Sao Paulo, Brazil. 5. Peter Munk Cardiac Centre, University Health Network, Toronto, Canada. 6. INSERM U-698, Paris, France; Université Paris-Diderot, Paris, France; Assistance Publique-Hôpitaux de Paris, Centre Hospitalier Bichat-Claude Bernard, Paris, France. 7. Clinical Trial and Surveys Corp., Baltimore, United States. 8. University of Verona/Instituti Ospedalieri, Verona, Italy. 9. Perth Cardiovascular Institute, Perth, Australia. 10. Green Lane Cardiovascular Service, Auckland, New Zealand. 11. Cardiovascular Clinical Research Center, New York University School of Medicine, New York, United States. Electronic address: Judith.Hochman@nyumc.org.
Abstract
BACKGROUND: The Occluded Artery Trial (OAT) randomized stable patients (n=2201)>24 h (calendar days 3-28) after myocardial infarction (MI) with totally occluded infarct-related arteries (IRA), to percutaneous coronary intervention (PCI) with optimal medical therapy, or optimal medical therapy alone (MED). PCI had no impact on the composite of death, reinfarction, or class IV heart failure over extended follow-up of up to 9 years. We evaluated the impact of early and late reinfarction and definition of MI on subsequent mortality. METHODS AND RESULTS:Reinfarction was adjudicated according to an adaptation of the 2007 universal definition of MI and the OAT definition (≥2 of the following--symptoms, EKG and biomarkers). Cox regression models were used to analyze the effect of post-randomization reinfarction and baseline variables on time to death. After adjustment for baseline characteristics the 169 (PCI: n=95; MED: n=74) patients who developed reinfarction by the universal definition had a 4.15-fold (95% CI 3.03-5.69, p<0.001) increased risk of death compared to patients without reinfarction. This risk was similar for both treatment groups (interaction p=0.26) and when MI was defined by the stricter OAT criteria. Reinfarctions occurring within 6 months of randomization had similar impact on mortality as reinfarctions occurring later, and the impact of reinfarction due to the same IRA and a different epicardial vessel was similar. CONCLUSIONS: For stable post-MI patients with totally occluded infarct arteries, reinfarction significantly independently increased the risk of death regardless of the initial management strategy (PCI vs. MED), reinfarction definition, location and early or late occurrence.
RCT Entities:
BACKGROUND: The Occluded Artery Trial (OAT) randomized stable patients (n=2201)>24 h (calendar days 3-28) after myocardial infarction (MI) with totally occluded infarct-related arteries (IRA), to percutaneous coronary intervention (PCI) with optimal medical therapy, or optimal medical therapy alone (MED). PCI had no impact on the composite of death, reinfarction, or class IV heart failure over extended follow-up of up to 9 years. We evaluated the impact of early and late reinfarction and definition of MI on subsequent mortality. METHODS AND RESULTS: Reinfarction was adjudicated according to an adaptation of the 2007 universal definition of MI and the OAT definition (≥2 of the following--symptoms, EKG and biomarkers). Cox regression models were used to analyze the effect of post-randomization reinfarction and baseline variables on time to death. After adjustment for baseline characteristics the 169 (PCI: n=95; MED: n=74) patients who developed reinfarction by the universal definition had a 4.15-fold (95% CI 3.03-5.69, p<0.001) increased risk of death compared to patients without reinfarction. This risk was similar for both treatment groups (interaction p=0.26) and when MI was defined by the stricter OAT criteria. Reinfarctions occurring within 6 months of randomization had similar impact on mortality as reinfarctions occurring later, and the impact of reinfarction due to the same IRA and a different epicardial vessel was similar. CONCLUSIONS: For stable post-MI patients with totally occluded infarct arteries, reinfarction significantly independently increased the risk of death regardless of the initial management strategy (PCI vs. MED), reinfarction definition, location and early or late occurrence.
Authors: Christian Spaulding; Patrick Henry; Emmanuel Teiger; Kevin Beatt; Ezio Bramucci; Didier Carrié; Michel S Slama; Bela Merkely; Andrejs Erglis; Massimo Margheri; Olivier Varenne; Ana Cebrian; Hans-Peter Stoll; David B Snead; Christoph Bode Journal: N Engl J Med Date: 2006-09-14 Impact factor: 91.245
Authors: P Buch; S Rasmussen; G H Gislason; J N Rasmussen; L Køber; N Gadsbøll; S Stender; M Madsen; C Torp-Pedersen; S Z Abildstrom Journal: Heart Date: 2006-08-29 Impact factor: 5.994
Authors: Judith S Hochman; Gervasio A Lamas; Genell L Knatterud; Christopher E Buller; Vladimir Dzavik; Daniel B Mark; Harmony R Reynolds; Harvey D White Journal: Am Heart J Date: 2005-10 Impact factor: 4.749
Authors: M P Hudson; C B Granger; E J Topol; K S Pieper; P W Armstrong; G I Barbash; A D Guerci; A Vahanian; R M Califf; E M Ohman Journal: Circulation Date: 2001-09-11 Impact factor: 29.690
Authors: Judith S Hochman; Gervasio A Lamas; Christopher E Buller; Vladimir Dzavik; Harmony R Reynolds; Staci J Abramsky; Sandra Forman; Witold Ruzyllo; Aldo P Maggioni; Harvey White; Zygmunt Sadowski; Antonio C Carvalho; Jamie M Rankin; Jean P Renkin; P Gabriel Steg; Alice M Mascette; George Sopko; Matthias E Pfisterer; Jonathan Leor; Viliam Fridrich; Daniel B Mark; Genell L Knatterud Journal: N Engl J Med Date: 2006-11-14 Impact factor: 91.245
Authors: Harvey D White; Harmony R Reynolds; Antonio C Carvalho; Camille A Pearte; Li Liu; C Edwin Martin; Genell L Knatterud; Vladimír Džavík; Mariusz Kruk; Philippe Gabriel Steg; Warren J Cantor; Venu Menon; Gervasio A Lamas; Judith S Hochman Journal: Am Heart J Date: 2012-04 Impact factor: 4.749
Authors: K Dönges; R Schiele; A Gitt; H Wienbergen; S Schneider; R Zahn; R Grube; B Baumgärtel; H G Glunz; J Senges Journal: Am J Cardiol Date: 2001-05-01 Impact factor: 2.778
Authors: Steven J Kernis; Kishore J Harjai; Gregg W Stone; Lorelei L Grines; Judith A Boura; Michael W Yerkey; William O'Neill; Cindy L Grines Journal: J Am Coll Cardiol Date: 2003-10-01 Impact factor: 24.094
Authors: R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith Journal: Br J Cancer Date: 1977-01 Impact factor: 7.640